Search - tctmd.com

Displaying 21 - 40 of 60

Sort: Relevancy | Date

Presentation TCT 2018

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Thomas Engstrøm

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Joo Myung Lee

September 24, 2018

Presentation TCT 2018

Management of Non-Culprit CTO in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Emmanouil S. Brilakis

September 24, 2018

Presentation TCT 2018

Rationale and Data for Multivessel PCI in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits

September 24, 2018

Presentation TCT 2018

Contemporary Assessment and Management of Coronary Calcium

Presenter: Margaret B. McEntegart, James Nolan, Anthony H. Gershlick

September 23, 2018

Presentation TCT 2018

CvLPRIT: Long-term Follow-up From a Randomized Trial of Early Complete Revascularization in Patients With Acute Myocardial Infarction and Multivessel Disease

Presenter: Jonathan M. Hill, E. Magnus Ohman, Anthony H. Gershlick

September 22, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Shelley Wood

March 12, 2018

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Anthony H. Gershlick

October 31, 2017

Presentation TCT 2017

TCT 179: Outcomes after Left Main PCI vs CABG According to Ostial/Shaft vs Distal Bifurcation Involvement: Insights From the EXCEL Trial

Presenter: Davide Capodanno, Tullio Palmerini, Anthony H. Gershlick

October 31, 2017

Presentation TCT 2017

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Presenter: Anthony H. Gershlick

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI With Multivessel Disease How We Treated

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Jacqueline E. Tamis-Holland

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Stefan K. James

October 30, 2017

Presentation TCT 2017

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick

October 29, 2017

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Anthony H. Gershlick

October 30, 2016

Presentation TCT 2016

Multivessel PCI in Cardiogenic Shock

Presenter: Stefan K. James, Holger Thiele, Anthony H. Gershlick

October 30, 2016

News Features

Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding

Yael L. Maxwell

June 29, 2016

News Features

急性脑卒中介入领域正在酝酿领地争夺战

Todd Neale

December 28, 2015

Advertisement

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Management of Non-Culprit CTO in STEMI

Rationale and Data for Multivessel PCI in STEMI

Contemporary Assessment and Management of Coronary Calcium

CvLPRIT: Long-term Follow-up From a Randomized Trial of Early Complete Revascularization in Patients With Acute Myocardial Infarction and Multivessel Disease

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

TCT 179: Outcomes after Left Main PCI vs CABG According to Ostial/Shaft vs Distal Bifurcation Involvement: Insights From the EXCEL Trial

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Case Resolution: STEMI With Multivessel Disease How We Treated

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Multivessel PCI in Cardiogenic Shock

Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding

急性脑卒中介入领域正在酝酿领地争夺战

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content